“Vesalius Biocapital Partners invests in companies active in human health through venture capital funds aised since 2017. We have contributed to developing 20 companies since inception.
With more than EUR 230 million under management in three funds; Vesalius Biocapital Partners plays the role of lead investor in the large majority of its fincancing rounds.
Our companies are based in Europe allowing easy interaction with management.
Vesalius invests in all stages of development and does not shy away from relatively early-stage projects with a sound proprietary technology and corresponding IP, unique team skills and a clear competitive edge based on solid data.
The investment strategie is focused on four ereas: therapeutics; medicals devices, diagnostics and e-health.”